Michael S. Vincent

Dr. Vincent is Senior Vice President and Chief Scientific Officer of the Inflammation and Immunology Research Unit at Pfizer, leading the scientific pipeline for Rheumatology, Gastroenterology, and Dermatology specialties through the end of Phase 2. Since joining Pfizer in 2011, he has held several scientific leadership roles, most recently as Clinical Head for Pharmatherapeutics in Cambridge, MA. Over this period, he has had responsibility for clinical and translational science in the Inflammation and Immunology, Rare Disease and the Cardiovascular and Metabolic Disease Research Units, and the Centers for Therapeutic Innovation. Before joining Pfizer, Dr. Vincent held positions of increasing responsibility within Medical Sciences at Amgen, ultimately leading early clinical development for the Immunology and Neuroscience therapeutic areas. Dr. Vincent earned his BA, Ph.D., and MD degrees from Indiana University, and completed his residency and began his post-doctoral and rheumatology training at the University of Vermont, completing his fellowship at Brigham and Women’s Hospital.